New York, NY and Rye Brook, NY (November 2, 2020) - The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society (LLS) announced today they are teaming up to support a research grants program of up to $10 million over five years, to build a more comprehensive understanding of hairy cell leukemia (HCL), develop better therapies and optimize outcomes for patients with HCL. The two organizations ...
Rye Brook, NY (Monday, October 26, 2020) - Patients participating in The Leukemia & Lymphoma Society’s (LLS) groundbreaking precision medicine Beat AML Master Clinical Trial had superior outcomes compared to acute myeloid leukemia (AML) patients who opted for standard chemotherapy treatment, according to findings published today in the prestigious Nature Medicine journal. The Beat AML trial achieved its prim...
Rye Brook, NY, September 24, 2020 – The Leukemia & Lymphoma Society (LLS), the world's largest nonprofit dedicated to fighting blood cancer, and the national off-price retailer, Burlington Stores, team up for the 19th consecutive year to raise critical funds for lifesaving research and cancer treatments. This year, funds raised in all Burlington store locations nationwide will not only support LLS’s...
Rye Brook, NY (Wednesday, Sept. 9, 2020) - With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-free, The Leukemia & Lymphoma Society (LLS) announced today it is launching the first clinical trial dedicated solely to this most vulnerable population. This trial (LLS Protocol Number: BAML-16-001-COV1) will tes...
Please send all media-related inquiries and interview requests to mediarelations@lls.org.
An LLS representative will respond as soon as possible.